Medline Industries, Inc., a leading name in the medical sector, is headquartered in the United States and operates extensively across North America and beyond. Founded in 1910, the company has established itself within the medical, precision, and optical instruments industry, focusing on the production and distribution of high-quality medical supplies and equipment.
Medline's core offerings include surgical instruments, wound care products, and infection prevention solutions, all designed to enhance patient care and operational efficiency in healthcare settings. The company is recognised for its commitment to innovation and quality, positioning itself as a trusted partner for healthcare providers. With a strong market presence and a reputation for excellence, Medline continues to achieve significant milestones, reinforcing its status as a leader in the medical supply industry.
+23 vs industry average
Medline Industries’s score of 50 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Medline Industries?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Medline Industries's reported carbon emissions
Medline Industries, based in the US and operating within the Medical, precision and optical instruments, watches and clocks (33) sector, reported a total of approximately 5.09 billion kg CO2e in 2024. This figure encompasses Scope 1, 2, and 3 emissions. Scope 1 emissions were approximately 133.23 million kg CO2e, while Scope 2 emissions amounted to roughly 141.26 million kg CO2e. Scope 3 emissions represented the largest portion, totalling approximately 4.81 billion kg CO2e, with purchased goods and services accounting for the most significant share at around 3.14 billion kg CO2e. In 2023, Medline Industries' total emissions were approximately 7.28 billion kg CO2e. Scope 1 emissions stood at approximately 173.84 million kg CO2e, and Scope 2 emissions were around 131.90 million kg CO2e. Scope 3 emissions were approximately 6.97 billion kg CO2e, primarily driven by purchased goods and services at approximately 5.68 billion kg CO2e. Medline Industries has established climate commitments, aiming for a near-zero state for its Scope 1 and 2 emissions by 2025. Furthermore, they are committed to reducing Scope 1 emissions by 30% and Scope 2 emissions by 30% from a 2023 baseline by 2030. Looking ahead to 2030, Medline Industries aims for an absolute reduction of 42% for Scope 1 and Scope 2 emissions, and an absolute reduction of 25% for Scope 3 emissions, using 2022 as the base year. The company also has long-term net-zero targets set for 2050. Earlier emissions data includes approximately 320.78 million kg CO2e in 2021, with Scope 1 at about 92.62 million kg CO2e, Scope 2 at approximately 72.04 million kg CO2e, and Scope 3 at about 156.12 million kg CO2e. In 2020, total emissions were approximately 243.73 million kg CO2e (Scope 1: 91.76 million kg CO2e, Scope 2: 98.70 million kg CO2e, Scope 3: 151.97 million kg CO2e). Emissions in 2019 were approximately 360.39 million kg CO2e (Scope 1: 79.98 million kg CO2e, Scope 2: 79.80 million kg CO2e, Scope 3: 200.62 million kg CO2e). In 2017, total emissions were approximately 305.63 million kg CO2e (Scope 1: 55.65 million kg CO2e, Scope 2: 90.16 million kg CO2e, Scope 3: 159.82 million kg CO2e). In 2015, emissions totalled approximately 217.12 million kg CO2e (Scope 1: 45.20 million kg CO2e, Scope 2: 81.31 million kg CO2e, Scope 3: 90.61 million kg CO2e). It is important to note that Medline Industries' emissions data is cascaded from its parent company, Medline Industries, Inc.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Medline Industries’s Climate Goals (2030 & 2050)
9 goals2030
42% reduction in all scopes
By 2030, our goal remains to achieve an absolute reduction of 42% by for Scope 1 and Scope 2 emissions and an absolute reduction of 25% for…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 9 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Medline Industries
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project